Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.

Claudio BazziTomoko UsuiVirginia RizzaDaniela CasellatoMaurizio GallieniMasaomi Nangaku

Published in: Nephrology (Carlton, Vic.) (2018)

Idiopathic membranous nephropathy subjects with high NAG/C and low eGFR have greater risk of progression, and immunosuppressive treatment is suggested at diagnosis.

Keyphrases

end stage renal disease
newly diagnosed
small cell lung cancer
ejection fraction
chronic kidney disease
prognostic factors
epidermal growth factor receptor
peritoneal dialysis
replacement therapy
smoking cessation